I'll second that Yahoo Tweakmax. Way to go Beacon Pharma!
G1a probably early 1980's, Biopsy F1(2010), F2-F3(2015). VL 5+mill; 2+mill (2014) Tx naive. Accessed Sof/Led through Dr Freeman at GP2U and Buyers Club (lifesavers!!!)
Commenced tx 12/11/15. 9 wk: VL <15 Detected but LFT = Normal 12 week results: UND (Yay!) Due to slow response commenced Sof/Dac 4 Feb for 12 weeks. EOT @ 24 weeks 27 April 2016. (With thanks to Dr Freeman et al). SVR11 result: VL 1,950,000. It's back!
New tx 030916 (Viekira Pak, Solvadi, Ribavirin UND @ 111116. EOT 170217.
SVR12 and SVR 24
I tried to go to the main company website and it said that the account was suspended and to contact my hosting provider. www.beacon-pharma.com
diagnosed in 2006
Treatment started 8/12/16, Ledipasvir/ Sofosbuvir (Harvoni) supplied by Monkmed
8/1/16 ALT 36 AST 40
1/4/17 ALT 17 AST 21
7/13/17 ALT 17 AST 25
12/28/17 ALT 22 AST26
2/22/18 ALT 19 AST 25
7/10/18 ALT 26 AST 32
1/8/19 ALT 16 AST 28
7/2/19 ALT 16 AST 26
Hcv Rna, Quantitative Real Time Pcr <15 NOT DETECTED (IU/mL) NOT DETECTED
Vindecat de HCV cu med. generice. Cured with generics HCV drugs.
Thank you received: 1594
same remark from my side, I believe in between the webpage changed and it needs to be updated also on this forum.
See my post from some minutes ago.
In fiecare an HCV ucide peste 500000 oameni.Medicamentele generice pentru hepatita C functioneaza. Nu deveni statistica! Cauta pe Google “medicamente generice pentru hepatita C”.
HCV kills more than 500000 people every year. HCV generic drugs work. Don't become a statistic.
By sharing this Youtube video you might save someone’s life!
My TX: HEPCVIR-L[generic Harvoni]-India
As per the current timelines GILEAD Licensed Velpatasvir will be available in early September 2016 in India. Epclusa( GILEAD Velpatasvir) is already licensed to Gilead’s 11 Indian manufacturing partners which includes top brands like Mylan,Cipla & Natco which have undergone a complete transfer of technology(TOT). en.wikipedia.org/wiki/Technology_transfer.
Licensing does not mean just a business aspect of royalty sharing but more importantly ensuring the quality of the licensed product is exactly same as that of the original pill. This aspect is ensured by rigorous TOT which is explained below.
A complete technology of transfer(TOT) means the process of manufacturing of the pills is exact same as of the original GILEAD pill not just limited to the API but aspects of Excipient which is the NON API materials that goes into the manufacturing en.wikipedia.org/wiki/Excipient.
On top of the above, premium companies like Cipla and Mylan have their own Quality assurance processes. So even if pills are manufactured by Hetero and Hetero has its own Quality Assurance and Testing of the pills, after they hand over the pills Cipla and Mylan have their own comprehensive Quality Assurance and Testing process . We like this aspect of double testing which is the precise reason doctors world over trust Cipla and Mylan.
Mylan has grown from the third-largest generic and pharmaceuticals company in the United States to the second-largest generic and specialty pharmaceuticals company in the world.en.wikipedia.org/wiki/Mylan.
On top of all the above all Indian manufacturing units that manufacture or sell Licensed products are US FDA certified and have to keep up with rigorous standards also called Current Good Manufacturing Practices (CGMPs)
Sofosvel is the 3rd product we launched as first global generic from beacon pharmaceuticals Ltd. Today is the world hepatitis day and launching of the Sofosvel (sofosbuvir + velpatasvir) is the great news for all hep c patients. They can get right treatment at affordable price. Our earlier two global first generic products were Tagrix (osimertinib) for lung cancer & Darvoni (sofosbuvir + daclatasvir) for all genotypes of hepatitis patients.
Not replying to my own post. Just giving this a 'bump' because it is literally the biggest and best news on generic treatment options in the whole world right now - and needs to stay at or near the top of the 'Recent Topics' section.